NALMEFENE FOR REDUCTION OF ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS

To provide a pharmaceutical composition for treating alcohol dependence of a patient with alcohol dependence.SOLUTION: The present invention provides a pharmaceutical composition containing nalmefene, where the composition reduces alcohol consumption in a patient, and the nalmefene is used for a pat...

Full description

Saved in:
Bibliographic Details
Main Authors CHRISTINE PERSSON, THOMAS JON JENSEN, DIDIER MEULIEN, ANNA BLADSTROM, AFSANEH ABBARIKI, LARS TORUP, JETTE BUCH OESTERGAARD, PER SOERENSEN
Format Patent
LanguageEnglish
Japanese
Published 26.09.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide a pharmaceutical composition for treating alcohol dependence of a patient with alcohol dependence.SOLUTION: The present invention provides a pharmaceutical composition containing nalmefene, where the composition reduces alcohol consumption in a patient, and the nalmefene is used for a patient identified to have a drinking risk level (DRL) corresponding to >60 g/day of pure alcohol consumption for men and >40 g/day for women.SELECTED DRAWING: None 【課題】アルコール依存症患者のアルコール依存症を治療するための医薬組成物の提供。【解決手段】ナルメフェンを含む医薬組成物であって、前記組成物は前記患者のアルコール消費を低減し、前記ナルメフェンが、男性では＞６０ｇ／日の純アルコール消費および女性では＞４０ｇ／日の純アルコール消費に対応するＤＲＬ（飲酒リスクレベル）を有すると識別される患者に用いられる、前記医薬組成物。【選択図】なし
Bibliography:Application Number: JP20190083718